TNFSF10 and glioma: The expression levels of these receptors have also been correlated with longer survival times for GBM patients.9 Unfortunately, many glioma cells are resistant to TRAIL-induced apoptosis, putting into question the clinical usefulness of TRAIL as a treatment.